Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

被引:187
作者
Tarkowski, E
Liljeroth, AM
Minthon, L
Tarkowski, A
Wallin, A
Blennow, K
机构
[1] Gothenburg Univ, Dept Rheumatol, Sect Neurol & Neurochem, S-41346 Gothenburg, Sweden
[2] Gothenburg Univ, Sect Neurol & Neurochem, Dept Clin Neurosci, S-41346 Gothenburg, Sweden
[3] Lund Univ, Dept Neuropsychiat, Malmo, Sweden
关键词
cytokines; gene polymorphism; apoptosis; dementia;
D O I
10.1016/S0361-9230(03)00088-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The knowledge regarding putative inflammatory component(s) participating in Alzheimer's disease (AD) and vascular dementia (VAD) is scarce. Recently, we have demonstrated the presence of certain inflammatory cytokines in the cerebrospinal fluid (CSF) of demented patients. Although the initial event(s) triggering the neurodegenerative processes in AD versus VAD may be different and lead to different neuropathological changes, it may initiate a similar cascade of cytokine production in response to neuronal injury. The cytokines released in the central nervous system (CNS) may, in turn, act in a similar manner in both diseases, amplifying some pathological changes such as amyloidogenesis and white matter lesions or on the contrary acting as neuroprotective molecules. This review will focus on the intracerebral production of the pro- and anti-inflammatory cytokines interleukin IL-1beta, IL-1 receptor antagonist (IL-1ra), IL-6 and TNF-alpha in dementia, and their relation to gene polymorphism, to cerebral neuronal damage, apoptosis, and to clinical variables of dementia. Our results, which show for the first time strikingly increased CSF levels of TNF-alpha but not of TNF-beta, IL-1beta or IL-6 in AD and VAD, may form a conceptual framework for further studies of neuroprotective mechanisms in dementias. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 51 条
[1]   THE PROTOONCOGENE BCL-2 CAN SELECTIVELY RESCUE NEUROTROPHIC FACTOR-DEPENDENT NEURONS FROM APOPTOSIS [J].
ALLSOPP, TE ;
WYATT, S ;
PATERSON, HF ;
DAVIES, AM .
CELL, 1993, 73 (02) :295-307
[2]   DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay [J].
Anderson, AJ ;
Su, JH ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE, 1996, 16 (05) :1710-1719
[3]   INCREASED IMMUNOREACTIVITY FOR JUN-RELATED AND FOS-RELATED PROTEINS IN ALZHEIMERS-DISEASE - ASSOCIATION WITH PATHOLOGY [J].
ANDERSON, AJ ;
CUMMINGS, BJ ;
COTMAN, CW .
EXPERIMENTAL NEUROLOGY, 1994, 125 (02) :286-295
[4]  
Banati Richard B., 1995, P1027
[5]   TUMOR-NECROSIS-FACTOR-ALPHA AND TUMOR-NECROSIS-FACTOR-BETA PROTECT NEURONS AGAINST AMYLOID BETA-PEPTIDE TOXICITY - EVIDENCE FOR INVOLVEMENT OF A KAPPA-B-BINDING FACTOR AND ATTENUATION OF PEROXIDE AND CA2+ ACCUMULATION [J].
BARGER, SW ;
HORSTER, D ;
FURUKAWA, K ;
GOODMAN, Y ;
KRIEGLSTEIN, J ;
MATTSON, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9328-9332
[6]   THE PARTICIPATION OF INTERLEUKIN-6 IN THE PATHOGENESIS OF ALZHEIMERS-DISEASE [J].
BAUER, J ;
GANTER, U ;
STRAUSS, S ;
STADTMULLER, G ;
FROMMBERGER, U ;
BAUER, H ;
VOLK, B ;
BERGER, M .
RESEARCH IN IMMUNOLOGY, 1992, 143 (06) :650-656
[7]   INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE [J].
BEAMER, NB ;
COULL, BM ;
CLARK, WM ;
HAZEL, JS ;
SILBERGER, JR .
ANNALS OF NEUROLOGY, 1995, 37 (06) :800-805
[8]   PRESENCE OF PARIETOTEMPORAL SYMPTOMATOLOGY DISTINGUISHES EARLY AND LATE ONSET ALZHEIMERS-DISEASE [J].
BLENNOW, K ;
WALLIN, A ;
GOTTFRIES, CG .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1991, 6 (03) :147-154
[9]   CYTOKINE REGULATION OF NEURONAL SURVIVAL [J].
BRENNEMAN, DE ;
SCHULTZBERG, M ;
BARTFAI, T ;
GOZES, I .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) :454-460
[10]   TUMOR NECROSIS FACTORS PROTECT NEURONS AGAINST METABOLIC EXCITOTOXIC INSULTS AND PROMOTE MAINTENANCE OF CALCIUM HOMEOSTASIS [J].
CHENG, B ;
CHRISTAKOS, S ;
MATTSON, MP .
NEURON, 1994, 12 (01) :139-153